Abstract
Corrected text The assignment of the institutions for two authors (Elisa Petruccioli and Christoph Lange) were not correct. The correct affiliations are as follows: Elisa Petruccioliz zTranslational Research Unit, National Institute for Infectious Diseases “Lazzaro Spallanzani”, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy. Christoph Langem, n, ad, az, bd mClinical Infectious Disease. Department of Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, Borstel, Germany nGerman Center for Infection Research (DZIF), Tuberculosis Unit, Borstel, Germany; adRespiratory Medicine & International Health, University of Lübeck, Lübeck, Germany; azGlobal TB Program, Baylor College of Medicine and Texas Childrenś Hospital, Houston, TX, USA.
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | 101523 |
| Zeitschrift | The Lancet Regional Health - Europe |
| Jahrgang | 59 |
| ISSN | 2666-7762 |
| DOIs |
|
| Publikationsstatus | Veröffentlicht - 12.2025 |
Fördermittel
The authors thank the following persons for their support during the study: Paola Mantegani, IRCCS San Raffaele Scientific Institute, Milan, Italy; Dr. Adrian Abagiu, Matei Bals Institute for Infectious Diseases in Bucharest, Romania; Franziska Daduna, Research center Borstel, Germany; Candida Guckelmus, Department of Transplant and Infection Immunology, Saarland University, Germany. Other sources of support: This study was investigator-initiated without 3rd party funding. For this study QuantiFERON-TB Gold Plus tests kits were donated to TBnet by the manufacturer (Qiagen, Hilden, Germany). Qiagen had no role in the idea, design and conduction of the study and had no access to study results at any time. C.L. is supported by the German Center for Infection Research (DZIF) under Grant agreement TTU-TB 02.709; DG and EP were partially supported by the Italian Ministry of Health , Ricerca Corrente, Linea 4.
| Träger | Trägernummer |
|---|---|
| Ministero della Salute | |
| Deutsches Zentrum für Infektionsforschung | TTU-TB 02.709 |
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)
DFG-Fachsystematik
- 2.21-05 Immunologie
Fingerprint
Untersuchen Sie die Forschungsthemen von „Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310 (The Lancet Regional Health - Europe (2025) 57, (S266677622500208X), (10.1016/j.lanepe.2025.101416))“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver